Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-14-005848
Filing Date
2014-03-26
Accepted
2014-03-26 17:34:22
Documents
2
Period of Report
2014-02-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 1768
2 ex24ulich.txt EX-24 2600
  Complete submission text file 0001179110-14-005848.txt   5909
Mailing Address C/O ALNYLAM PHARMACEUTICALS, INC 300 THIRD STREET CAMBRIDGE MA 02142
Business Address
Ulich Thomas R (Reporting) CIK: 0001291960 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-52089 | Film No.: 14719563

Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Issuer) CIK: 0001292519 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus